Department of Radiopharmacy, Karolinska University Hospital, Stockholm, Sweden.
Department of Oncology and Pathology, Kaolinska Institutet, Stockholm, Sweden.
J Labelled Comp Radiopharm. 2021 Jun 30;64(8):346-352. doi: 10.1002/jlcr.3926. Epub 2021 May 29.
We report herein an efficient and fully automated protocol for the radiosynthesis of [ F]FAPI-74, a new positron emission tomography (PET) radiopharmaceutical for in vivo detection of the fibroblast activation protein. [ F]FAPI-74 was synthesized via a rapid [ F]aluminum fluoride coordination reaction, which was first developed on the flexible GE TRACERLab FX2N (FXN) platform and later translated to the cassette-based module Trasis AllInOne (AIO). The results obtained with both modules were comparable in terms of yield and reproducibility. Automation of [ F]FAPI-74 radiosynthesis on the FXN was carried out in 35 min with a radiochemical yield (RCY) of 18.5 ± 2.5% (n = 5, relative to starting [ F]fluoride). Method transfer to the AIO platform following minor optimizations allowed for the production of [ F]FAPI-74 in an isolated RCY of 20 ± 2.5% [n = 3] with an overall synthesis time of 40 min. The radiochemical purity was greater than 95% for [ F]FAPI-74, obtained from both modules. Overall, the protocol reliably provides a sterile and pyrogen-free good manufacturing practice (GMP) compliant product of [ F]FAPI-74 suitable for clinical PET imaging.
我们在此报告一种高效且全自动的 [ F]FAPI-74 放射性合成方案,这是一种新的正电子发射断层扫描(PET)放射性药物,用于体内检测成纤维细胞激活蛋白。[ F]FAPI-74 通过快速的 [ F] 氟化铝配位反应合成,该反应最初是在灵活的 GE TRACERLab FX2N(FXN)平台上开发的,后来又转化为基于盒式模块的 Trasis AllInOne(AIO)。这两个模块的结果在产率和重现性方面相当。在 FXN 上自动化 [ F]FAPI-74 放射性合成用时 35 分钟,放射性化学产率(RCY)为 18.5±2.5%(n=5,相对于起始 [ F] 氟化物)。经过少量优化后,将该方法转移到 AIO 平台上,可在 40 分钟的总合成时间内,以 20±2.5%[n=3]的孤立 RCY 生产 [ F]FAPI-74。从这两个模块获得的 [ F]FAPI-74 的放射化学纯度均大于 95%。总的来说,该方案可靠地提供了一种无菌且无热原的符合良好生产规范(GMP)的 [ F]FAPI-74 产品,适用于临床 PET 成像。